These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16393284)

  • 1. Poor response to 18-month lamivudine monotherapy in chronic hepatitis B patients with IgM anti-HBc and acute exacerbation.
    Chen JJ; Lin CY; Sheu MJ; Kuo HT; Sun CS; Tang LY; Wang SL; Tsai SL
    Aliment Pharmacol Ther; 2006 Jan; 23(1):85-90. PubMed ID: 16393284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine monotherapy for chronic hepatitis B infection with acute exacerbation revisited.
    Sheu MJ; Kuo HT; Lin CY; Koay LB; Lee C; Chen JJ; Tang LY; Tsai SL
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):447-51. PubMed ID: 19190496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine response of IgM anti-HBc chronic hepatitis B patients.
    Gómez-Domínguez E; García-Buey L; Gisbert JP; Moreno-Otero R
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1757-8; author reply 1758-60. PubMed ID: 16817920
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y; Tang Q; Zhu W; Zhang X; You L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Virological, serological and clinical characteristics of anti-HBc IgM positive chronic hepatitis B patients].
    Zhang CZ; Tian ZX; Shi SZ; Li MH; Xie Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):138-40. PubMed ID: 17653316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study.
    Tsubota A; Arase Y; Saitoh S; Kobayashi M; Suzuki Y; Suzuki F; Chayama K; Murashima N; Ikeda K; Kobayashi M; Kumada H
    Am J Gastroenterol; 2001 Feb; 96(2):557-62. PubMed ID: 11232706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
    Manolakopoulos S; Bethanis S; Elefsiniotis J; Karatapanis S; Triantos C; Sourvinos G; Touloumi G; Economou M; Vlachogiannakos J; Spandidos D; Avgerinos A; Tzourmakliotis D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):787-95. PubMed ID: 16556181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B].
    Shi KD; Hwang SG; Choi JH; Hwang IJ; Yoon JH; Kim KI; Kwon CI; Hong SP; Park PW; Rim KS
    Korean J Hepatol; 2008 Jun; 14(2):197-205. PubMed ID: 18617767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B.
    Chan HL; Wong VW; Hui AY; Tsang SW; Chan JL; Chan HY; Wong GL; Sung JJ
    Antivir Ther; 2006; 11(4):465-71. PubMed ID: 16856620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment.
    Uzun Y; Bozkaya H; Erden E; Cinar K; Idilman R; Yurdaydin C; Uzunalimoglu O
    J Gastroenterol Hepatol; 2006 Jun; 21(6):977-81. PubMed ID: 16724981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing outcome of lamivudine in anti-HBe-positive chronic hepatitis B.
    Ascione A; Ascione T; Lanza AG; Utech W; Di Costanzo GG; Macri M
    Hepatogastroenterology; 2006; 53(72):919-23. PubMed ID: 17153453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity.
    Kondo Y; Asabe S; Kobayashi K; Shiina M; Niitsuma H; Ueno Y; Kobayashi T; Shimosegawa T
    J Med Virol; 2004 Nov; 74(3):425-33. PubMed ID: 15368520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection.
    Tsuda F; Naito S; Takai E; Akahane Y; Furuta S; Miyakawa Y; Mayumi M
    Gastroenterology; 1984 Jul; 87(1):159-64. PubMed ID: 6724259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values.
    Alexopoulou A; Baltayiannis G; Eroglu C; Nastos T; Dourakis SP; Archimandritis AJ; Karayiannis P
    J Med Virol; 2009 Jan; 81(1):34-41. PubMed ID: 19031457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
    Galli C; Orlandini E; Penzo L; Badiale R; Caltran G; Valverde S; Gessoni G
    J Med Virol; 2008 Jun; 80(6):974-9. PubMed ID: 18428144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?
    Orlando R; Tosone G; Tiseo D; Piazza M; Portella G; Ciancia R; Martinelli V; Montante B; Rotoli B
    Infection; 2006 Oct; 34(5):282-4. PubMed ID: 17033754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of immunoglobulin A antibody to hepatitis B core antigen of polymeric and monomeric forms in chronic type B liver disease with acute exacerbation.
    Nomura M; Douchin M; Tokuda A; Sato F; Ito S; Kohli Y; Fujiki N
    Am J Gastroenterol; 1988 Dec; 83(12):1390-4. PubMed ID: 3195545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B.
    Huang YW; Lin CL; Chen PJ; Lai MY; Kao JH; Chen DS
    J Gastroenterol Hepatol; 2006 May; 21(5):859-62. PubMed ID: 16704536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.